论文部分内容阅读
目的观察阿德福韦酯联合苦参素治疗慢性乙型肝炎(CHB)的疗效。方法治疗组40例患者应用阿德福韦酯联合苦参素治疗,对照组40例应用阿德福韦酯单一治疗,对比分析3、6、12个月HBV DNA阴转率与HBeAg/HBeAb血清转换率。结果治疗组治疗6、12个月后HBV DNA阴转率及HBeAg/HBeAb血清转换率均高于对照组(P<0.05)。结论阿德福韦酯联合苦参素治疗慢性乙型肝炎疗效较单用阿德福韦酯疗效显著。
Objective To observe the efficacy of adefovir dipivoxil and oxymatrine in the treatment of chronic hepatitis B (CHB). Methods Forty patients were treated with adefovir dipivoxil combined with oxymatrine and 40 patients in the control group were treated with adefovir dipivoxil. The negative rates of HBV DNA negative conversion at 3, 6 and 12 months were compared with that of HBeAg / HBeAb serum Conversion rate. Results After 6 and 12 months of treatment, the seroconversion rate of HBV DNA and the rate of HBeAg / HBeAb seroconversion in the treatment group were higher than those in the control group (P <0.05). Conclusion Adefovir dipivoxil combined with oxymatrine treatment of chronic hepatitis B effect than adefovir dipivoxil alone significantly.